1. Home
  2. KEN vs EVO Comparison

KEN vs EVO Comparison

Compare KEN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenon Holdings Ltd.

KEN

Kenon Holdings Ltd.

HOLD

Current Price

$65.88

Market Cap

3.5B

Sector

Utilities

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.95

Market Cap

778.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEN
EVO
Founded
2014
1993
Country
Singapore
Germany
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
778.3M
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
KEN
EVO
Price
$65.88
$1.95
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
15.1K
46.0K
Earning Date
05-27-2026
04-08-2026
Dividend Yield
4.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
$9.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.50
$1.89
52 Week High
$95.93
$4.27

Technical Indicators

Market Signals
Indicator
KEN
EVO
Relative Strength Index (RSI) 49.00 40.09
Support Level $64.41 $1.90
Resistance Level $70.47 $2.20
Average True Range (ATR) 1.28 0.05
MACD 0.13 0.02
Stochastic Oscillator 53.02 17.74

Price Performance

Historical Comparison
KEN
EVO

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include: OPC Power Plants, which generates and supplies electricity and energy in Israel; and CPV Group, which generates and supplies electricity and energy in the United States. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: